Cemiplimab-Rwlc Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL
Reference Brands: Libtayo (USA/EU)
Category: Oncology Cancer Care
Cemiplimab-rwlc is a monoclonal antibody (PD-1 inhibitor) used to treat various cancers, including metastatic or locally advanced cutaneous squamous cell carcinoma, basal cell carcinoma, and certain types of non-small cell lung cancer. It works by boosting the immune system’s ability to detect and destroy cancer cells. Cemiplimab-rwlc is available in Injection and strengths such as 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cemiplimab-rwlc is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Cemiplimab-rwlc can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Cemiplimab-rwlc is used to treat metastatic or locally advanced cutaneous squamous cell carcinoma, metastatic basal cell carcinoma, and advanced non-small cell lung cancer.
Cemiplimab-rwlc is a recombinant human monoclonal IgG4 antibody that targets the PD-1 receptor.
The trade name is Libtayo.
Libtayo is made by Regeneron Pharmaceuticals in collaboration with Sanofi.
The generic name is cemiplimab-rwlc.
The brand name is Libtayo.
It is manufactured in the United States by Regeneron Pharmaceuticals.
Related Products
Gemtuzumab Ozogamicin
Strength:
4.5 mg
Form: Injection
Reference Brands: Mylotarg (USA)
View Details
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
